Blood markers and long-term problems after a first leg blood clot
Studies blood markers and later complications in people with a first leg blood clot.
Key facts
- Who runs it
- Ove Andersen
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Deep Venous Thrombosis and Long Term Complications
- Status
- Recruiting
- People taking part
- 178 people, planned
- Started
- 14 Mar 2023
- Expected to end
- 1 Sept 2029
- Type of study
- Interventional
- Treatments tested
- Blood sample and Ultrasound examination
- Record updated
- 23 February 2026
Who can take part
The trial is looking for adults admitted to the Emergency Department with a first blood clot in a deep vein of the leg (DVT). It studies blood markers and long-term problems over 2 years.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- First time deep vein blood clot (DVT) in the leg, while in the Emergency Department
- Main reasons for not taking part
- No Danish social security number
- Patients at the end of life (terminal illness)
- Not able to understand or speak Danish
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- 18 years or above
- First time lower extremity DVT
- Hospitalized at the Emergency Department
Who cannot take part
- Patients without a Danish social security number
- Terminal patients
- Patients who do not understand or speak Danish
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- DVT of legs
This trial is currently available in Denmark.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In this cohort study, the investigators will investigate the concentration of biomarkers, e.g., inflammatory, anti-inflammatory, immunological, senescent, biochemical ratio-calculations, blood cell type, and and long term complications with a 2-year follow-up in patients with first time lower extremity deep venous thrombosis
The group in the trial
- Biomarkers and long term complications in DVT patientsOther group
Patients with DVT will be enrolled in the study during their hospitalization at the ED. The enrolled patients will have 4 follow-up visits, 1) during the first 14 days after diagnosis, 2) after 3 months, 3) after 12 months and 4) 24 months after the time of diagnosis.
Treatment: Blood sample and Ultrasound examination
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Deep Venous Thrombosis and Risk of Long Term Complications in Acutely Admitted Patients
- Plain-language title
- Blood markers and long-term problems after a first leg blood clotGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT05789108, who can take part
- Record updated
- 23 February 2026